Endoscopic ultrasound guided biopsy of focal liver lesions: a tertiary care single center experience
Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S161
DOI: 10.1055/s-0044-1783044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von G. Rancatore und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Aims
To evaluate the efficacy and safety of EUS-FNB of focal liver lesions.
Methods
All consecutive patients who underwent EUS-FNB of a focal liver lesion between 2003 and 2023 were retrospectively analyzed. All procedures were performed with patients under deep sedation. Efficacy was evaluated considering technical success, adequacy and accuracy of histological diagnosis. Adequacy was defined as the ability of the technique to confer a histological diagnosis. Accuracy was define as the agreement between definitive histology after surgery (for resectable patients), radiologic findings or clinical course during follow-up. “Malignant” was defined as a case with histologically malignant findings”, and “benign” cases were those with “histologically benign findings on EUS-FNB and no tumor growth even after one-year follow-up”. Sensitivity and specificity were also evaluated. Adverse events were defined according to American Society of Gastrointestinal Endosocopy (ASGE) lexicon.
Results
A total of 58 patients were included in our analysis. Of these, 43 patients had a final diagnosis of malignancy including 7 cases of hepatocellular carcinoma, 16 cases of cholangiocarcinoma, 16 metastasis, 3 cases of malignant neoplasm of unclear origin and 1 Kaposi ’s sarcoma. A total of 12 patients received a final diagnosis of benign disease. Only in 3 cases the specimen was suboptimal for histological evaluation. The adequacy and accuracy were 95% and 96% respectively. Technical success was 100%. The sensitivity and specificity were 95% and 100% respectively. The localization of lesions were 72.4% (42 cases) in the left lobe and 27.6% (16 cases) in the right lobe. No intra/postprocedural adverse events were recorded.A tot Conclusions Our data suggest that liver lesions are mainly approachable through EUS when located in the left lobe, close to big vessels or in obese patients, with high diagnostic performances and reducing the risk of AEs than other techniques.EUS-guided biopsy of focal liver lesions is effective and safe. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Rancatore, G., Ligresti, D., Rizzo, G. M., Carrozza, L., Traina, M., & Tarantino, I. (2024). Endoscopic ultrasound guided biopsy of focal liver lesions: a tertiary care single center experience. Endoscopy, 56(S 02 S 02), S161. https://doi.org/10.1055/s-0044-1783044
Vancouver
Rancatore G, Ligresti D, Rizzo GM, Carrozza L, Traina M, Tarantino I. Endoscopic ultrasound guided biopsy of focal liver lesions: a tertiary care single center experience. Endoscopy. 2024;56(S 02 S 02):S161. doi:10.1055/s-0044-1783044
BibTeX
@article{Rancatore2024,
author = {Rancatore, G. and Ligresti, D. and Rizzo, G.E. M. and Carrozza, L. and Traina, M. and Tarantino, I.},
title = {Endoscopic ultrasound guided biopsy of focal liver lesions: a tertiary care single center experience},
journal = {Endoscopy},
year = {2024},
volume = {56},
number = {S 02 S 02},
pages = {S161},
doi = {10.1055/s-0044-1783044}
}
EUVIMED